Neurology · 2024 · 30 citations · 45 references
MedicineNeurologyNeuroscienceDementiaGlial BiologyNeurodegenerationAlzheimer DiseaseCognitive ImpairmentDementia BiomarkersDementia Risk FactorsNeurodegenerative DiseasesNeuroinflammationAge-related NeuroinflammationAmyloid Beta PlaquesAmyloid PlaquesNeuroinflammation In Alzheimer DiseaseNeuroinflammatory Biomarkers
BACKGROUND AND OBJECTIVES: positivity (CSF±) and Aβ-PET positivity (PET±) in older adults without dementia. Associations of Aβ deposition, cortical thickness, glucose metabolism, and microglial activation were also investigated. METHODS: in the plasma and CSF were investigated. Baseline and slopes of regional FBP SUVR were compared among Plasma±/PET± groups, and associations of regional FBP SUVR, FDG SUVR, cortical thickness, and CSF soluble Triggering Receptor Expressed on Myeloid Cell 2 (sTREM2) levels were analyzed. RESULTS: < 0.05) CSF sTREM2 increase in Plasma+/PET- individuals rather than in Plasma+/PET+ individuals. DISCUSSION: and Aβ-PET abnormalities. Higher sTREM2-related microglial activation is linked to thicker cortical thickness and higher metabolism in early amyloidosis stages but tends to mitigate Aβ accumulation primarily at relatively advanced stages.
45
Guy M. McKhann, David S. Knopman, Howard Chertkow et al. · Alzheimer s & Dementia · 2011 · 18.8K citations · Full text
Thomas K. Karikari, Tharick A. Pascoal, Nicholas J. Ashton et al. · The Lancet Neurology · 2020 · 1.4K citations · Full text
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Suzanne E. Schindler, James G. Bollinger, Vitaliy Ovod et al. · Neurology · 2019 · 903 citations · Full text